✦ LIBER ✦

Antiparkinsonian Action of a δ Opioid Agonist in Rodent and Primate Models of Parkinson's Disease

✍ Scribed by C.J. Hille; S.H. Fox; Y.P. Maneuf; A.R. Crossman; J.M. Brotchie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiparkinsonian effects of remacemide h

✍ Dr. J. Timothy Greenamyre; Robert V. Eller; Zhiming Zhang; Aliza Ovadia; Roger K 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Antiparkinsonian Actions of Ifenprodil i

✍ J.E. Nash; S.H. Fox; B. Henry; M.P. Hill; D. Peggs; S. McGuire; Y. Maneuf; C. Hi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 73 KB

μ- and δ-Opioid Receptor Antagonists Red

✍ Brian Henry; Susan H. Fox; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Evaluation of the mGluR2/3 agonist LY379

✍ Tracey K Murray; Marcus J Messenger; Mark A Ward; Sandra Woodhouse; David J Osbo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 491 KB

Modulation of glutamate release by a κ-o

✍ Michael P. Hill; Jonathan M. Brotchie 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Primate model of Parkinson's disease: al

✍ Nadav Zamir; Gerhard Skofitsch; Michael J. Bannon; Cinda J. Helke; Irwin J. Kopi 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 365 KB